Evidence map›Paper›PMID 36262961›Full record

ArticleJournal of orthopaedic translation2022

Acceleration of bone formation by octacalcium phosphate composite in a rat tibia critical-sized defect.

Cheol-Hee Jeong, Jooseong Kim, Hyun Sil Kim, Song-Yi Lim, Dawool Han, Aaron J Huser, Sang Bae Lee, Yeonji Gim, Jeong Hyun Ji, Dohun Kim and 3 more

Abstract read
In one paragraph

Article in Journal of orthopaedic translation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Looking forward to a better 2023 and beyond.Journal of orthopaedic translation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cheol-Hee JeongDepartment of Oral Pathology, Yonsei University College of Dentistry, Seoul, South Korea.
Jooseong KimDepartment of Biomedical Engineering, Yeungnam University, Daegu, Republic of Korea.
Hyun Sil KimDepartment of Oral Pathology, Yonsei University College of Dentistry, Seoul, South Korea.
Song-Yi LimDepartment of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.
Dawool HanDepartment of Oral Pathology, Yonsei University College of Dentistry, Seoul, South Korea.
Aaron J HuserPaley Advanced Limb Lengthening Institutute, St. Mary's Hospital, West Palm Beach, FL, USA.
Sang Bae LeeCenter for Testing and Evaluation of Dental Biomaterials, Ministry of Food and Drug Safety Recognition Laboratory, Yonsei University College of Dentistry, Seoul, South Korea.
Yeonji GimDepartment of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.
Jeong Hyun JiDepartment of Laboratory Animal Resources, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Dohun KimDepartment of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.
Amaal M AldosariDepartment of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.
Kyelim YunHudensBio Co., Ltd., Gwangju, Republic of Korea.
Yoon Hae KwakDepartment of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The osteogenic capabilities and biodegradability of octacalcium phosphate (OCP) composites make them unique. Despite the excellent characteristics of OCP, their use is limited due to handling difficulties. In this study, we aimed to evaluate and compare three types of OCPs (cemented OCP (C-OCP), C-OCP with collagen (OCP/Col), and synthetic OCP (S-OCP) with alginate (OCP/Alg)) versus commercially available β-tricalcium phosphate (β-TCP) regarding their potential to accelerate bone formation in defective rat tibias. Methods: The specimens with OCP composite were manufactured into 5 ​mm cubes and inserted into the segmental defects of rat tibias fixed with an external fixator. In addition, 3 ​mm-hole defects in rat tibias were evaluated to compare the graft material properties in different clinical situations. Serial X-ray studies were evaluated weekly and the tibias were harvested at postoperative 6 weeks or 8 weeks for radiologic evaluation. Histological and histomorphometric analyses were performed to evaluate the acceleration of bone formation. Results: In the critical-defect model, OCP/Alg showed bone bridges between segmentally resected bone ends that were comparable to those of β-TCP. However, differences were observed in the residual graft materials. Most β-TCP was maintained until 8 weeks postoperatively; however, OCP/Alg was more biodegradable. In addition calcification in the β-TCP occurred at the directly contacted area between graft particles and bony ingrowth was observed in the region adjacent resected surface of tibia. In contrast, no direct bony ingrowth was observed in OCP-based materials, but osteogenesis induced from resected surface of tibia was more active. In the hole-defect model, OCP/Col accelerated bone formation. β-TCP and OCP/Alg showed similar patterns with relatively higher biodegradability. In histology, among the OCP-based materials, directly contacted new bone was formed only in OCP/Alg group. The new bone formation in the periphery area of graft materials was much more active in the OCP-based materials, and the newly formed bone showed a thicker trabecular and more mature appearance than the β-TCP group. Conclusions: In this study, OCP/Alg was equivalent to β-TCP in the acceleration of bone formation with better biodegradability appropriate for clinical situations in different circumstances. Our OCP/Col composite showed fast degradation, which makes it unsuitable for use in mechanical stress conditions in clinical orthopedic settings. The Translational Potential of this Article: In our research, we compared our various manufactured OCP composites to commercially available β-TCP in critical-defect rat tibia model. OCP/Col showed acceleration in hole-defect model as previous studies in dental field but in our critical-sized defect model it resorbed fast without acceleration of bony union. OCP/Alg showed matched results compared to β-TCP and relatively fast resorption so we showed market value in special clinical indication depending on treatment strategy. This is the first OCP composite study in orthopaedics with animal critical-sized tibia bone study and further study should be considered for clinical application based on this study.

Indexed as

Bone regenerationBone substituteCritical-sized defectOctacalcium phosphateβ-tricalcium phosphate

Identifiers

PMID36262961
PMCPMC9574596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.